These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 3810649)
1. Antitrust implications of joint negotiations with third party payers. Rainer JM Top Health Care Financ; 1986; 13(2):79-85. PubMed ID: 3810649 [No Abstract] [Full Text] [Related]
2. Evaluating antitrust risk in joint provider negotiations with payors. Leonard EJ Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450 [TBL] [Abstract][Full Text] [Related]
3. Are PPOs a competitive force or antitrust risk? Enders RJ Healthc Financ Manage; 1986 May; 40(5):52-60. PubMed ID: 10276171 [TBL] [Abstract][Full Text] [Related]
5. The development of preferred provider organizations and its antitrust implications. Maram BS J Med Pract Manage; 1985 Oct; 1(2):130-5. PubMed ID: 10281825 [TBL] [Abstract][Full Text] [Related]
6. Can provider antitrust suits against payers be successful? Enders RJ Healthc Financ Manage; 1986 Jun; 40(6):72-80. PubMed ID: 10276682 [TBL] [Abstract][Full Text] [Related]
10. The FTC and provider-controlled PPO price negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(3):6-10. PubMed ID: 10285716 [No Abstract] [Full Text] [Related]
13. Antitrust and the new competition in health care: excerpts. Ginsburg DH Med Prod Sales; 1986 Apr; 17(4):39-42. PubMed ID: 10276459 [No Abstract] [Full Text] [Related]
14. More private, less government PPA antitrust action. Burda D Hospitals; 1987 Feb; 61(3):52. PubMed ID: 3804258 [No Abstract] [Full Text] [Related]
15. Court: Indiana Blues may adopt PPO plan without antitrust scrutiny. Allen HS; Rothschild IS Health Law Vigil; 1986 Apr; 9(8):4-5. PubMed ID: 10278389 [No Abstract] [Full Text] [Related]
16. High court ruling cuts antitrust risk for hospitals and their subsidiaries. Hirshfeld EB; Roach WH Mod Healthc; 1984 Oct; 14(13):182-5. PubMed ID: 10268408 [No Abstract] [Full Text] [Related]
17. Proposed FTC consent order first to prohibit PPO price-fixing and concerted negotiations. Miles JJ Health Law Vigil; 1988 Jan; 11(2):9-10, 14. PubMed ID: 10285312 [No Abstract] [Full Text] [Related]
19. The primacy of standard antitrust analysis in health care. Weller CD Spec Law Dig Health Care (Mon); 1984 Dec; 6(10):7-35. PubMed ID: 10268834 [No Abstract] [Full Text] [Related]
20. Alternative delivery systems are focus of antitrust scrutiny. Scammon DL; Fuller DA; Sheffet MJ J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715 [No Abstract] [Full Text] [Related] [Next] [New Search]